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Purpose: We have previously reported that tetra-cell adhesion molecule (T-CAM) markedly enhanced the differentiation of 
osteoblast-like cells grown on anorganic bone mineral (ABM). T-CAM comprises recombinant peptides containing the Arg-
Gly-Asp (RGD) sequence in the tenth type III domain, Pro-His-Ser-Arg-Asn (PHSRN) sequence in the ninth type III domain of 
fibronectin (FN), and the Glu-Pro-Asp-Ilu-Met (EPDIM) and Tyr-His (YH) sequence in the fourth fas-1 domain of βig-h3. There-
fore, the purpose of this study was to evaluate the cellular activity of osteoblast-like cells and the new bone formation on ABM 
coated with T-CAM, while comparing the results with those of synthetic cell binding peptide (PepGen P-15).
Methods: To analyze the cell viability, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed, and   
to analyze gene expression, northernblot was performed. Mineral nodule formations were evaluated using alizarin red stain. 
The new bone formations of each group were evaluated using histologic observation and histomorphometrc analysis.
Results:  Expression of alkaline phosphatase mRNA was similar in all groups on days 10 and 20. The highest expression of os-
teopontin mRNA was observed in the group cultured with ABM/P-15, followed by those with ABM/T-CAM and ABM on days 
20 and 30. Little difference was seen in the level of expression of collagen type I mRNA on the ABM, ABM/T-CAM, and ABM/
P-15 cultured on day 20. There were similar growth and proliferation patterns for the ABM/T-CAM and ABM/P-15. The halo of 
red stain consistent with Ca
2+ deposition was wider and denser around ABM/T-CAM and ABM/P-15 particles than around the 
ABM particles. The ABM/T-CAM group seemed to have bone forming bioactivity similar to that of ABM/P-15. A complete bony 
bridge was seen in two thirds of the defects in the ABM/T-CAM and ABM/P-15 groups. 
Conclusions:  ABM/T-CAM, which seemed to have bone forming bioactivity similar to ABM/P-15, was considered to serve as 
effective tissue-engineered bone graft material. 
Keywords:  Bone substitutes, Cell adhesion molecules, Cell survival.
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Research Article
INTRODUCTION
Implantation of bone graft materials to stimulate bone de-
position has been used in periodontal therapy since the 1970s. 
Recently different graft materials, including demineralized 
and non-mineralized freeze-dried bone allografts, various 
types of natural and synthetic hydroxyapatite, ceramics, cal-
cium carbonate, and synthetic polymers have been utilized 
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as bone graft materials. Bone grafts have long been used in 
reconstructive surgery with the aim of increasing the bone 
volume in the previous defect area. An ideal bone graft or bone 
substitute material should presumably have the following 
characteristics: sterility, not eliciting any immunological re-
action, osteoconductivity or osteoinductivity, favorable clini-
cal handling, ability to be resorbed and replaced by bone, 
availabiliy in sufficient quantities, and low cost [1].
The autogenous bone graft is the material most likely to 
possess both osteoconductive and osteoinductive properties 
[2,3]. However, in an attempt to avoid separate surgical pro-
cedures involving a remote donor siteand reduce postsurgi-
cal pain, patient inconvenience, operating time and cost, cli-
nicians have increased their use of alternative grafting mate-
rials. 
The recent development of tissue engineering makes it 
possible to envision the association of autologous cell and/or 
proteins that promote cell adhesion with osteoconductive 
material to create osteoinductive materials. Based on this 
concept, commercially available synthetic cell binding pep-
tide (PepGen P-15, Dentsply Friadent CeraMed, Lakewood, 
CO, USA) developed. PepGen P-15 is biomimetic biomaterial 
composed of anorganic bone mineral (OsteoGraf/N-300, 
Dentsply Friadent CeraMed) and a synthetic peptide (P-15) 
that mimics the cell-binding domain of type I collagen re-
sponsible for cell migration, proliferation, and differentiation 
[4]. A synthetic 15-residue peptide, which is analogous to the 
sequence 
766GTPGPQGIAGQRGVV
780 in the α1 (I) chain, is re-
lated to a biologically active portion of type I collagen [5].
Theoretical studies have shown that the central GIAG se-
quence of this P-15 sequence has a high potential for a stable 
β-bend [6]. It has been demonstrated in vitro that the anorganic 
bone mineral/P-15 (ABM/P-15) enhances the attachment of 
cells and provides an environment that is permissive for cell 
migration, cell differentiation, and morphogenesis [4,7,8]. In 
addition, experimental studies have reported that the use of 
the materials in small and large bony defects enhances new 
bone formation [9-11].
Recently, we reported [12] that the cell adhesion molecule 
tetra-cell adhesion molecule (T-CAM) markedly enhanced 
the differentiation of osteoblast-like cells grown on ABM. T-
CAM is composed of recombinant peptides containing the 
Arg-Gly-Asp (RGD) sequence in the tenth type III domain, the 
Pro-His-Ser-Arg-Asn (PHSRN) sequence in the ninth type III 
domain of fibronectin (FN), and the Glu-Pro-Asp-Ilu-Met 
(EPDIM) and Tyr-His (YH) sequence in the fourth fas-1 do-
main of βig-h3. The RGD peptide signaling domain derived 
from fibronectin interacts with several cell surface integrins, 
the major one being α5β1 [13,14], and promotes osteoblast 
adhesion [15]. The PHSRN sequence within the ninth type III 
domain serves as a synergistic site that enhances the binding 
affinity of the RGD sequence [16]. βig-h3 induced by TGF-β is 
an ECM protein that has four internal repeat domains 
named fas-1 [17,18] and has been considered to promote cell 
adhesion and spreading through the α3β1 and αvβ5 integrin 
mediating EPDIM and YH sequences within the fourth fas-1 
domain [19,20]. Therefore, both sequences of RGD and 
PHSRN in T-CAM are recognized by integrin α5β1 in osteo-
blasts-like cells [21]. EPDIM and YH in T-CAM may be recog-
nized by integrin α3β1 and αvβ5 in osteoblast-like cells [19,20].
Therefore, the purpose of this study was to evaluate the cel-
lular activity of osteoblast-like cells and new bone formation 
on ABM coated with T-CAM, while comparing the results 
with those of ABM coated with a synthetic peptide which 
mimics the cell-binding domain of type I collagen, PepGen 
P-15.
MATERIALS AND METHODS
Experimental materials 
PepGen P-15, anorgnic bone mineral (OsteoGraf/N-300) 
coated with synthetic P-15, which is analogous to the sequence 
766GTPGPQGIAGQRGVV
780 in the α1 (I) chain of type I colla-
gen and ABM in a particulate form (OsteoGraf/N-300) and 
OsteoGraf/N-300 for the carrier of T-CAM were obtained 
from Dentsply Friadent CeraMed.
Peptide synthesis
T-CAM is a fusion protein consisting of the 9th and 10th 
type III domains of fibronectin and the 4th fas-1 domain of 
βig-h3. A fragment of fibronectin cDNA, encoding amino 
acids 1,330 to 1,513 was generated by polymerase chain reac-
tion and restricted to the Nde I and Nsil I sites. The Nde I/
Nsil I fragment of fibronectin cDNA was inserted into the 
EcoRV sites of the 4th fas-1 domain of βig-h3 [19]. Plasmid 
constructs encoding T-CAM were transformed into BL21 (DE3) 
for expression. Overnight bacterial culture was induced by 1 
mM IPTG for 3 hours and T-CAM protein was purified using 
Ni-NTA resin (Qiagen, Hilden, Germany) according to the 
manufacturer’s recommendations [19]. 
Preparation of ABM/T-CAM
For study of the effect of T-CAM on cellular activity of os-
teoblast-like cells and new bone formation in rabbit calvarial 
defects, the peptide was absorbed into ABM by incubating 0.5 
g ABM for 24 hours in a concentration of 100 µg/mL T-CAM. 
The incubation was carried out at room temperature with 
gentle shaking to ensure equilibration of the peptide with all 
the exposed surfaces of the microporous ABM. Following in-
cubation, the ABM was washed three times by shaking with a Journal of Periodontal
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5× volume of phosphate buffered saline (PBS) over a 24 hours 
period to remove unabsorbed peptide. The ABM powder was 
collected and dried in a dry oven. ABM with T-CAM absorbed 
peptide was generated using sterilized preparations.
Osteoblast culture on ABM, ABM/T-CAM, and ABM/P-15
We used the mouse calvaria-derived MC3T3-E1 osteoblast-
like cell line for this study. MC3T3-E1 cells were cultured in 
alpha-modified Eagle’s medium (Gibco, Grand Island, NY, 
USA) supplemented with 10% fetal bovine serum (FBS, Gib-
co) and 500 unit/mL penicillin (Kunwha Pharmaceutical Co., 
Seoul, Korea), 500 µg/mL streptomycin (Dong-A Pharmaceu-
tical Co., Seoul, Korea) and cultured in an atmosphere of 100% 
humidity, 5% CO2, and 37°C. Cells were grown in 10% FBS 
containing 10 mM β-glycero-phosphate (Sigma-Aldrich Co., 
St. Louis, MO, USA), 50 µg/mL of ascorbic acid and 100 nM 
dexamethasone in 100 mm dishes or 24 well plates (Corning 
Inc., Corning, NY, USA) for the experiments. The medium 
was changed every 3 days.
The experimental groups were classifiedas follows:
ABM: OsteoGraf/N-300 particles in polystyrene petri dishes
ABM/T-CAM: OsteoGraf/N-300 particles absorbed in T-
CAM in polystyrene petri dishes
ABM/P-15: OsteoGraf/N-300 particles absorbed in P-15 
(PepGen P-15) in polystyrene petri dishes
MTT assay for viable cell numbers
MTT (3-[4,5-dimethylthiazol-2yl]-2, 5 diphenyltetrazolium 
bromide; thiazolyl blue) assay is transformed by mitochon-
drial dehydrogenases into formazan, enabling mitochondrial 
activity and cell viability to be assessed. The cultured cells 
were seeded at an initial density of 2×10
4 cells/well on each 
well containing each particle of the 24 well plate. Three kinds 
of particles (30 mg/well)-ABM, ABM/T-CAM and ABM/P-
15-were used in each group. The cells were cultured in an 
atmosphere of 100% humidity, 5% CO2, and 37°C for 1, 4, and 
7 days. They were then removed from the medium and 
washed with PBS two times. Then, 250 µL of MTT solution 
prewarmed to 37°C was added to each well and incubated for 
3 hours in the same condition and 750 µL of dimethyl sulfox-
ide (DMSO) and 250 µL of glycine buffer were added. The 
solution was transferred to 96-well plates that did not contain 
the particles. The optical density was measured at a wave-
length of 570 nm by an enzyme-linked immunosorbent as-
say (ELISA) reader (Precision Microplate Reader, Molecular 
Devices Co., Sunnyvale, CA, USA). 
Gene expression for bone matrix protein
The cultured cells were seeded at an initial density of 8×10
4 
cells/well. The wells contained 150 mg/well of particles fromthe 
100 mm petri dishes. The cells were cultured in an atmo-
sphere of 100% humidity, 5% CO2, and 37°C for 10 and 20 
days for alkaline phosphatase (ALP) and during 10, 20, and 30 
days for osteopontin (OPN) and collagen type I (Col I).
Total RNA was extracted from the cultured cells by using a 
modified acid phenol method. Ten µg of total RNA was heat-
ed to 65°C for 15 minutes in 50% formamide, 0.02% formal-
dehyde, 40 nM MOPS (3-[-N-morpholino]propanesulfonic 
acid), 10 mM sodium acetate, 1 mM ethylenediaminetetraace-
tic acid (EDTA), and 0.1 mg/mL ethodium bromide prior to 
gel electrophoresis on 1% agarose, 55% formaldehyde, 40 mM 
MOPS, 10 mM sodium acetate, and 1 mM EDTA. The RNA 
was blotted onto Hybond-N+Membranes (Amersham Bio-
sciences, Uppsala, Sweden) in 20X SSC. The RNA was air-
dried and then cross-linked by exposure to ultraviolet light. 
The probes were labelled with [a-P
32]-dCTP by a Megaprime 
DNA labeling system kit (Amersham Biosciences). Prehy-
bridization and hybridization were performed by using the 
Express Hyb solution (Clontech, Mountain View, CA, USA). 
After hybridization, the membrane was washed in 2X SSC - 
0.1% sodium dodecyl sulfate (SDS) at room temperature and 
then in 0.1X SSC/0.1% SDS at 55°C, and exposed to Agfa X-ray 
film at -70°C with intensifying screens.
Staining with alizarin red for mineralization
Red staining with alizarin red is an indicator of mineraliza-
tion [22]. MC3T3-E1 cell cultures on ABM, ABM/T-CAM, and 
ABM/P-15 were prepared for staining by removing the medi-
um, washing the cells with PBS, and fixing them in 2% para-
formaldehyde for 30 minutes at 4°C following which the cells 
were gently washed with H2O. The cells were stained in a so-
lution of 1% alizarin red S, pH 4.2 for 10 minutes at room 
temperature, and then, the cells were washedwith H2O two 
times. The samples were air dried, and were then examined 
and photographed in a light microscope.
Animal study for evaluation of new bone formation
Eight adult male New Zealand White rabbits weighing 3.0 
to 3.5 kg were used in this study. This experiment was ap-
proved by the Institutional Animal Careand Use Committee 
of Kyungpook National University Hospital, Daegu, Korea. 
The animals were anesthetized preoperatively with an intra-
muscular injection of ketamine hydrochloride of 44 mg/kg 
of body weight (Ketalar, Yuhan, Seoul, Korea) and xylazine of 
7 mg/kg of body weight (Rompun, Bayer Korea Ltd, Seoul, 
Korea). Two full thick skull defects were made in the parietal 
bones with a trephine bur (3i Implant Innovations Inc., Palm 
Beach Gardens, FL, USA). The defects were rinsed with sterile 
saline and then filled with the ABM/T-CAM and ABM/P-15 Journal of Periodontal
& Implant Science JPIS
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graft materials. 
The defects were evaluated at 4 weeks after implantation. 
The specimens were fixed with the mixture of 4% parafor-
maldehyde in 0.1 M PBS. After fixation, the specimens were 
sectioned at 5 µm with a microtome and stained with Mas-
son’s trichrome.
Statistical analysis
The data analysis of this study was analyzed using the sta-
tistical software package (SAS, SAS Institute Inc., Cornelius, 
NC, USA). In the cellular activity of osteoblast-like cells, the 
Student-Newman-Keuls test was used to determine the sta-
tistical significance of the three groups. All values are ex-
pressed as means±standard deviations. Statistical signifi-
cance was established at P<0.01. 
RESULTS
MTT assay for cellular viability 
Cell proliferation and viability inthe ABM, ABM/T-CAM, 
and ABM/P-15 groups were measured by MTT assay at 1, 4, 
and 7 days and the results are presented in Fig. 1. The MTT 
assay indicated the increases in viable cell numbers of the 
ABM, ABM/T-CAM, and ABM/P-15 groups according to the 
time. The cell numbers were significantly higher in ABM/T-
CAM and ABM/P-15 groups at 4 and 7 days (P<0.01), compared 
to the ABM group. We also observed these results on hema-
toxylin and eosin stains at 4 day culture (Fig. 2).
The expression of ALP mRNA, OPN mRNA, and Col I 
mRNA 
Fig. 3 shows the expression of alkaline phosphatase mRNA 
of the cells cultured with the ABM, ABM/T-CAM, and ABM/
P-15 on days 10 and 20. Expression of alkaline phosphatase 
mRNA was also similar in all groups on days 10 and 20. The 
groups cultured on day 10 showed higher expression of alka-
line phosphatase mRNA than the groups cultured on day 20.
Fig. 4 shows the expression of osteopontin mRNA and col-
lagen type I mRNA of the cells cultured with the ABM, ABM/
T-CAM, and ABM/P-15 on days 10, 20, and 30. Among the ex-
perimental groups, the highest expression of osteopontin 
mRNA was observed in the group cultured with ABM/P-15, 
followed by those with ABM/T-CAM and ABM on day 20. 
Furthermore, the expression of osteopontin mRNA was high-
er in all groups cultured on day 10 and 20 than in all groups 
cultured on day 30. The expression of OPN mRNA on ABM/
T-CAM and ABM/P-15 was similar to that on ABM at 10 days 
culture. Although little difference was seen in the level of ex-
pression of collagen type I mRNA on the ABM, ABM/T-CAM, 
and ABM/P-15 cultured on day 20, greater expression was ob-
served in the 30 day culture on ABM/T-CAM and ABM/P-15 
than on ABM. 
Figure 1.  Optical density measured after culture for 1, 4, and 7 days 
at a wavelength of 579 nm by an enzyme-linked immunosorbent 
assay reader (n=3 in each groups). The optical density of anorganic 
bone mineral/tetra-cell adhesion molecule (ABM/T-CAM) and ABM/ 
P-15 was significantly higher than ABM alone on days 4 and 7. 
a)A 
statistically significant difference as compared with ABM (P<0.01). 
ABM: OsteoGraf/N-300 particles in polystyrene petri dishes, ABM/
T-CAM: OsteoGraf/N-300 particles absorbed T-CAM in polystyrene 
petri dishes, ABM/P-15: OsteoGraf/N-300 particles absorbed P-15 
(PepGen P-15) in polystyrene petri dishes.
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Figure 2.  Cellular viability of anorganic bone mineral (ABM), ABM/
tetra-cell adhesion molecule (ABM/T-CAM), and ABM/P-15 at 4 day 
culture stained by H&E. (A) ABM (×40), (B) ABM (×100), (C) ABM/T-
CAM (×40), (D) ABM/T-CAM (×100), (E) ABM/P-15 (×40), (F) ABM/
P-15 (×100). MC3T3-E1 cells were attached in remarkably great 
numbers on ABM/T-CAM and ABM/P-15 than on ABM.
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Staining with alizarin red
The growth and mineralization pattern of osteoblast-like 
cells cultured with ABM, ABM/T-CAM and ABM/P-15 was ex-
amined using a phase-contrast microscope after staining with 
alizarin red S at 30 day culture (Fig. 5). There were similar 
growth and proliferation patterns for the ABM/T-CAM and 
ABM/P-15. In these groups, the cells formed multicellular lay-
ers around the graft material and interparticular bridges be-
tween them. Multicellular layers and interparticular bridges 
were also observed in cultures with ABM, but only in afew 
cases. 
Very strong staining with the dye was seen in osteoblast-
like cell cultures on ABM, ABM/T-CAM, and ABM/P-15. Fig. 
5A, 5C, and 5E show staining around isolated ABM, ABM/T-
CAM, and ABM/P-15 particles. The halo of red stain consis-
tent with Ca
2+ deposition was wider and denser around the 
ABM/T-CAM and ABM/P-15 particles than around the ABM 
particles. 
New bone formation in rabbit calvarial defects 
The histologic findings at 4 weeks of healing are shown in 
Fig. 6. The ABM/T-CAM group seemed to have similar bone 
ALP
Day 10 Day 20
rRNA
ABM ABM ABM/T-CAM ABM/T-CAM ABM/P-15 ABM/P-15
Figure 3.  Gene expression of alkaline phosphatase (ALP) of MC3T3-
E1 cells cultured on anorganic bone mineral (ABM), ABM/tetra-cell 
adhesion molecule (ABM/T-CAM), and ABM/P-15 for 10 and 20 days. 
The ALP activity of MC3T3-E1 cells on ABM/T-CAM and ABM/P-15 
was similar to that of ABM. ABM: OsteoGraf/N-300 particles in 
polystyrene petri dishes, ABM/T-CAM: OsteoGraf/N-300 particles 
absorbed on T-CAM in polystyrene petri dishes, ABM/P-15: Osteo-
Graf/N-300 particles absorbed on P-15 (PepGen P-15) in polystyrene 
petri dishes.
OPN
Day 10 Day 20 Day 30
Col I
rRNA
ABM ABM ABM ABM/T-CAM ABM/T-CAM ABM/T-CAM ABM/P-15 ABM/P-15 ABM/P-15
Figure 4.  Gene expression of osteopontin (OPN) and α1 (I) collagen (Col I) of MC3T3-E1 cells cultured on anorganic bone mineral (ABM), 
ABM/tetra-cell adhesion molecule (ABM/T-CAM), ABM/P-15 for 10, 20, and 30 days. The expression of OPN mRNA on ABM/T-CAM and 
ABM/P-15 was similar to that of ABM at 10 days culture, but was remarkably higher on ABM/T-CAM and ABM/P-15 than ABM at 20 days 
culture. The expression of Col 1 mRNA on ABM/T-CAM and ABM/P-15 was similar to that of ABM at 20 days culture. ABM: OsteoGraf/
N-300 particles in polystyrene petri dishes, ABM/T-CAM: OsteoGraf/N-300 particles absorbed T-CAM in polystyrene petri dishes, ABM/
P-15: OsteoGraf/N-300 particles absorbed P-15 (PepGen P-15) in polystyrene petri dishes.
Figure 5.  Staining with alizarin red S on anorganic bone mineral 
(ABM), ABM/tetra-cell adhesion molecule (ABM/T-CAM), and ABM/
P-15 at 30 day culture. (A) ABM (×40), (B) ABM (×100), (C) ABM/T-
CAM (one particle  ×100), (D) ABM/T-CAM (particles  ×100), (E) 
ABM/P-15 (one particle ×100), (F) ABM/P-15 (particles ×100). There 
were similar growth and proliferation patterns for ABM/T-CAM 
and ABM/P-15. In these groups, the cells formed multicellular layers 
around the graft material and interparticular bridges between them. 
Multicellular layers were also observed in the cultures with ABM, 
but fewer. The halo of red stain consistent with Ca
2+ deposition is 
wider and denser around the ABM/T-CAM and ABM/P-15 particles 
than around the ABM particles. 
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forming bioactivity to the ABM/P-15 group. A complete bony 
bridge was seen in two thirds of the defects in the ABM/T-
CAM and ABM/P-15 groups (Fig. 6A-a and B-a). Newly formed 
bone was seen in direct apposition to the bone particles (Fig. 
6A-b). The new mineralized tissue consisted of woven bone 
characterized by a high number of randomly distributed 
large osteocytes and by irregularly arranged fiber bundles 
within the new bone matrix (Fig. 6A-c and B-c). Among the 
particles, the direct union of new bone was favorably observed 
(Fig. 6A-c and B-c). At the defect margin, the new bone that 
had emerged from the old bone was mature (Fig. 6B-b). 
DISCUSSION
Bone formation is related to the adherence of osteoblasts 
to graft material. The adherence can be enhanced by coating 
graft materials with certain cell binding peptides of the ex-
tracellular matrix. The interaction of osteoblasts with the ex-
tracellular matrix proteins represents essential environmen-
tal signals necessary for regulating proliferation and differ-
entiation of osteoblasts [23]. This interaction is mediated pri-
marily through the integrin family [24]. Osteoblasts express a 
wide array of integrin heterodimers, both in vivo and in vitro, 
particularly those interacting with the extracellular matrix 
proteins of bone [25-27]. A number of investigators report the 
expression of a broad range of integrin subunits in bone cells, 
including α1β1, α2β1, α3β1, α5β1, αvβ3, and αvβ5 [25,26,28]. 
Both sequences of RGD and PHSRN in fibronectin are rec-
ognized by integrin a5β1 in osteoblast-like cells [21]. EPDIM 
and YH in 4th fas-1 domain of βig-h3 may be recognized by 
integrin α3β1 and αvβ5 in osteoblast-like cells [19,20]. 
Collagen also modulates cell differentiation mechanically 
and chemically [7,29]. The involvement of a specifc chain of 
15 peptides in the processes of cell differentiation was dem-
onstrated for the first time by Qian and Bhatnagar [4] in 1996. 
This amino acid sequence (766-780 of the a1 chain of the type 
1 collagen) is responsible for cell bonding and the initiation 
of a cascade of events that lead to the formation of new bone, 
and is also referred to as P-15. The ABM/P-15 bone graft ma-
terial has been shown in vitro to enhance the attachment of 
cells [4,7,29], and to enhance bone formation within a shorter 
time interval compared with the composite graft material of 
HA and autogenous bone in the human maxillary sinus eval-
uation procedure [30].
We synthesized T-CAM, which is the recombinant protein 
containing an RGD sequence in the tenth type III domain 
and a PHSRN sequence in the ninth type III domain of fi-
bronectin, and a YH sequence and EPDIM sequence in the 
fourth fas-1domain of βig-h3, and we evaluated the cellular 
activity of osteoblast-like cells and new bone formation to 
ABM coated with T-CAM , while comparing the results with 
those of ABM coated with a synthetic peptide (P-15) that 
mimics the cell-binding domain of type I collagen, PepGen 
P-15. 
Using the MTT assay for the cellular viability of osteoblast-
like cells, astatistical difference in cell viability was observed 
when osteoblast-like cells were cultured for 4 and 7 days on 
ABM/T-CAM and ABM/P-15 compared to ABM. It was con-
cluded that the increase in cellular viability of ABM/T-CAM 
was due to four cellular adhesion molecules absorbed to hy-
Figure 6.  Histologic findings of defects filled with anorganic bone mineral/tetra-cell adhesion molecule (ABM/T-CAM) (A) and ABM/P-15 
(B) at 4 weeks (Masson’s Trichorome stain). (a) Whole findings (×25), (b) High magnification (×100), (c) High magnification (×100). (▼: mar-
gin defect, G: graft material, NB: new bone). A complete bony bridge was seen in two thirds of the defects in the ABM/T-CAM and ABM/
P-15 groups (A-a and b). Newly formed bone was seen in direct apposition to the graft material (A-b). The new mineralized tissue consisted 
of woven bone characterized by a high number of randomly distributed large osteocytes and by irregularly arranged fiber bundles within 
the new bone matrix (A-c). At the margin of the defect, the new bone that had emerged from the old bone was mature (B-b). Among the 
graft materials, the direct union of new bone was favorably observed (A and B-c).
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droxyapatite, which was similar to another study [31]. They 
reported that the proliferation of periodontal ligament cells 
in FN fragments containing FN type III ninth-tenth domain 
fragmentsdid not differ statistically from those in FN. The 
results on ABM/P-15 might be explained by the mechanism 
of enhanced cell proliferation resulting from the type I colla-
gen binding of the P-15 peptide [4,7,29].
In order to study the osteoblastic characteristics of cultured 
cells, we examined the expression of several genes implicat-
ed in osteoblastic differentiation. The expression of ALP 
mRNA was also similar in all groups on days 10 and 20. The 
groups cultured on day 10 showed a higher expression of 
ALP mRNA than the groups cultured on day 20. It was dem-
onstrated that osteoblast-like cells reached the highest ALP 
activity level after 7 to 10 days [32]. Also, the ALP decrease 
could represent a maturation of osteoblasts [33]. Col I is es-
sential for bone formation and matrix production in bone 
and is expressed from the early stages of differentiation on-
wards [34]. All groups’ cells showed a similar level of Col I 
mRNA expression at 10 and 20 days. This result was similar 
to that of the study which reported that a similar level of Col 
I mRNA expression was shown in Algipore, Bio-Oss and Pep-
Gen P-15 cultured on day 6 and 21 [35]. OPN is also a marker 
for osteoblastic differentiation and is expressed in the early 
stages as well as in the postprolierative period of osteoblastic 
growth [34]. Our investigations showed expression of OPN 
throughout the entire culture period in all groups. However, 
the expression of OPN was lowest in all the groups cultured 
on day 30. It was considered that differentiation of osteo-
blasts almost terminated at this period. The regulation of 
OPN expression correlates with bone development where an 
increase in an osteopontin expression level reduces prolifera-
tion as well as induces differentiation of osteoblasts [36-38]. 
Among the experimental groups, the highest expression of 
osteopontin mRNA was observed in the group cultured with 
ABM/P-15, followed by those with ABM/T-CAM and ABM on 
day 20, the periods between the bone matrix formation/mat-
uration and mineralization stages. Our results support the 
idea that ABM/T-CAM and ABM/P-15 provide an appropriate 
environment for MC3T3-E1 cells to undergo differentiation 
into mature osteoblasts. This implies that the biomimetic 
surface of ABM/T-CAM and ABM/P-15 was involved not only 
in cell proliferation but also in regulation of cellular differen-
tiation. 
The growth and mineralization pattern of osteoblast-like 
cells cultured with ABM, ABM/T-CAM, and ABM/P-15 was 
examined by staining with alizarin red S at 30 day culture. 
The halo of red staining around the isolated ABM/T-CAM 
and ABN/P-15 particles was wider than that around the ABM. 
This pattern was similar to a study reporting that a halo of 
red stain consistent with Ca
2+ deposition can be seen in hu-
man gingival firoblast matrix associated with ABM/P-15 [29]. 
The presence of a halo stain surrounding ABM particles can 
be deduced to be associated with a newly mineralized matrix 
produced by the cells. Therefore, the marked stain associated 
with the 3-D cellular colony on the surface of ABM/T-CAM 
and ABM/P-15 particles indicated that ABM/T-CAM and 
ABM/P-15 particles could induce more mineralization than 
ABM particles. The interparticular bridges comprised of cells 
were seen in ABM, ABM/T-CAM, and ABM/P-15 cultures, but 
it was much more intense and frequent in ABM/T-CAM and 
ABM/P-15 cultures. The cells in these bridges play a major 
role in the clustering of particles by generating tractional 
forces. Mechanical stimulation stimulates bone formation 
and inhibits bone resorption in cultured bone tissue and 
cells [39].
Mechanical stimulation induced by biomimetic surfaces of 
ABM/T-CAM and ABM/P-15 might increase the mineraliza-
tion of osteoblast-like cells. 
In this study, ABM/T-CAM seemed to have similar bone 
forming bioactivity compared to ABM/P-15 in vivo. A complete 
bony bridge was seen in two thirds of defects in the ABM/T-
CAM and ABM/P-15 groups on week 4. These results corre-
sponded to the hypothesis that a recombinant P-15 binding 
domain was a prerequisite for a multifocal formation of new 
bone in the defect filled with PepGen P-15, where the new 
bone was not organized exclusively starting from vital bone 
walls unlike the classical defect healing process [40]. These 
findings indicated that the cell-binding peptides of type I 
collagen and synthetic peptide related to cell adhesion con-
tributed to favorable new bone formation. 
The data presented here support our hypothesis that im-
mobilizing T-CAM, composed of four cell adhesion mole-
cules (RGD, PHSRN in fibronectin and EPDIM, YH in βig-h3) 
on ABM, will enhance the ability of the ceramic matrix to 
serve as a host for osteoblast-like cells. The ability of ABM/T-
CAM is similar to that of ABM/P-15.
In conclusion, ABM/T-CAM, which seemed to have similar 
bone forming bioactivity to ABM/P-15, was found to serve as 
an effective tissue-engineered bone graft material.
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